Sion Wyn

Conformity Ltd.
Director
Sion Wyn, Director, Conformity Ltd., is an acknowledged international expert in computer system validation and compliance. He was consultant to US FDA during the re-examination of 21 CFR Part 11, and a core member of the team that produced the FDA Guidance on 21 CFR Part 11 Scope and Application. He was the technical content expert for the FDA’s ORA Virtual University on-line training modules on computerized systems validation and compliance. He received the FDA Group Recognition Award for work on Part 11. Wyn is a GAMP founder member, Editor of the ISPE GAMP 5 Guide A Risk Based Approach to Compliant GxP Computerized Systems, and a member of the ISPE GAMP Global Steering Committee and GAMP Editorial Board. Wyn is a GAMP, Data Integrity, and Part 11 trainer and course developer for ISPE, and is technical consultant to ISPE.
At Conformity Ltd., Wyn provides computer validation and compliance consultancy to the pharmaceutical and other regulated life-science industries. Wyn received the 2006 ISPE Professional Achievement Award, which honours an ISPE Member who has made a significant contribution to the pharmaceutical manufacturing industry. He received the ISPE UK Fellow Award in 2010.

Related Articles

IT Services: Applying Good IT Practice & Automation
Features
IT Services: Applying Good IT Practice & Automation

This article focuses on pragmatic quality- and risk-based approaches to IT infrastructure. It covers recommendations made by a US FDA/industry team linked to the US FDA Center for Devices and Radiological Health (CDRH) Case for Quality initiative1

  • 1US Food and Drug Administration Center for Devices and Radiological Health. “Case for Quality.” 29 July 2020.
A Gamp® Approach to Robotic Process Automation
Features
A GAMP® Approach to Robotic Process Automation

This article introduces the concept of robotic process automation (RPA) and discusses how the technology may be used within a GAMP® framework to support both non-GxP and GxP processes.

Why ISPE GAMP® Supports the FDA CDRH: Case for Quality Program
Features
Why ISPE GAMP® Supports the FDA CDRH: Case for Quality Program

The US FDA Center for Devices and Radiological Health (CDRH) Case for Quality program promotes a risk-based, product quality–focused, and patient-centric approach to computerized systems. This approach encourages critical thinking based on product and process knowledge and quality risk management over prescriptive documentation-driven approaches.